Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, May 5 2017

Full Issue

'Gray Death' Is A Particularly Lethal Opioid Mixture That's Infiltrating Street Drug Market

“Gray death is one of the scariest combinations that I have ever seen in nearly 20 years of forensic chemistry drug analysis,” says Deneen Kilcrease, manager of the chemistry section at the Georgia Bureau of Investigation. In other news, a sales representative for an opioid maker talks about his secret addition. And highway safety officials say that drug-impaired driving is a growing problem.

The Associated Press: 'Gray Death' Is The Latest Opioid Street Mix Causing Worry

It’s being called “gray death” — a new and dangerous opioid combo that underscores the ever-changing nature of the U.S. addiction crisis. Investigators who nicknamed the street mixture have detected it or recorded overdoses blamed on it in Alabama, Georgia and Ohio. The drug looks like concrete mix and varies in consistency from a hard, chunky material to a fine powder. The substance is a combination of several opioids blamed for thousands of fatal overdoses nationally, including heroin, fentanyl, carfentanil — sometimes used to tranquilize large animals like elephants — and a synthetic opioid called U-47700. (Welsh-Huggins, 5/4)

Stat: Sales Executive For Opioid Maker Was Addicted To The Drug He Promoted

As a district sales manager for Insys Therapeutics, Jeffrey Pearlman led a team that aggressively pushed doctors to widely prescribe the company’s highly addictive opioid painkiller Subsys. He even threatened to stop paying a nurse speaking fees if she didn’t help boost sales of the drug, emails show. All the while, Pearlman held a secret: He himself was addicted to opioids like the very ones he was promoting. (Armstrong, 5/5)

NPR: Measuring Drug Impairment In Drivers Easier Said Than Done

Drug-impaired driving is a growing concern for highway safety officials. But, as a recent report makes clear, its actual impact is still difficult to measure. The report from the Governors Highway Safety Association, a group of state highway safety offices, found that in 2015, among fatally injured drivers with a known test result, drugs were detected more frequently than alcohol. (Hobson, 5/5)

And from Georgia and Minnesota —

The Associated Press: Georgia Governor Signs Limits On Drug Treatment Centers

Georgia is increasing regulation of addiction treatment centers, prompted by complaints from northwest Georgia lawmakers and residents that a cluster of programs there largely treat people traveling from other states. Gov. Nathan Deal signed the legislation on Thursday. (5/4)

The Star Tribune: Minneapolis VA Study Finds Opioids No Better For Chronic Pain Than Other Meds 

First-of-its-kind research at the Minneapolis VA has found no long-term benefits for patients taking opioid medications for chronic pain — a finding that is likely to strengthen the case for reducing use of the addictive medications that have been responsible for a sharp rise in drug overdoses and deaths. Focusing on patients who suffer from chronic back pain or arthritic knees and hips, the study compared 120 who didn’t receive opioids with 120 who did as part of their pain management. (Olson, 5/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF